These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 7010029

  • 21. A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up.
    Herskovits E, Vazquez A, Famulari A, Tamaroff L, Fraiman H, Gonzáles AM, Smud R, Vila J, Matera V.
    Ric Clin Lab; 1981; 11 Suppl 1():257-64. PubMed ID: 6765140
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
    Gengo FM, Rainka M, Robson M, Gengo MF, Forrest A, Hourihane M, Bates V.
    J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
    [Abstract] [Full Text] [Related]

  • 23. [Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents].
    De Martiis M, Parenzi A, Barlattani A, De Martiis A.
    Clin Ter; 1986 Mar 15; 116(5):367-71. PubMed ID: 3519061
    [No Abstract] [Full Text] [Related]

  • 24. Antiplatelet drugs for ischemic stroke prevention.
    Leys D, Balucani C, Cordonnier C.
    Cerebrovasc Dis; 2009 Mar 15; 27 Suppl 1():120-5. PubMed ID: 19342841
    [Abstract] [Full Text] [Related]

  • 25. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM.
    Circulation; 1980 Dec 15; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [Abstract] [Full Text] [Related]

  • 26. Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy.
    Aushri Z, Berginer V, Nathan I, Dvilansky A.
    Int J Clin Pharmacol Res; 1983 Dec 15; 3(5):339-42. PubMed ID: 6206005
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Aspirin for transient ischemic attacks.
    Med Lett Drugs Ther; 1980 Aug 22; 22(17):71-2. PubMed ID: 6995822
    [No Abstract] [Full Text] [Related]

  • 29. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
    Diener HC.
    MMW Fortschr Med; 2003 May 26; 145 Suppl 2():111. PubMed ID: 14579505
    [No Abstract] [Full Text] [Related]

  • 30. [Prevention of vascular complications after cerebral ischemia of arterial origin. European Stroke and Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT): moderated coagulation, aspirin-dipyridamole combination or aspirin alone?].
    De Schryver EL, Gorter JW, Algra A, van Gijn J.
    Rev Med Interne; 1999 May 26; 20(5):397-9. PubMed ID: 10365408
    [No Abstract] [Full Text] [Related]

  • 31. For your stroke-prone patients: a guide to drug treatment.
    Yatsu FM.
    Geriatrics; 1980 Feb 26; 35(2):34-47. PubMed ID: 7356588
    [No Abstract] [Full Text] [Related]

  • 32. Transient ischemic attacks: Part II. Treatment.
    Solenski NJ.
    Am Fam Physician; 2004 Apr 01; 69(7):1681-8. PubMed ID: 15086040
    [Abstract] [Full Text] [Related]

  • 33. Treating thromboembolic disease.
    Deykin D, Gurewich V, Harker L, Hirsch J.
    Geriatrics; 1977 Oct 01; 32(10):119-21, 125-8. PubMed ID: 302814
    [No Abstract] [Full Text] [Related]

  • 34. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK, Vécsei L.
    Ideggyogy Sz; 2008 May 30; 61(5-6):148-54. PubMed ID: 18567389
    [Abstract] [Full Text] [Related]

  • 35. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):752-5. PubMed ID: 16139120
    [Abstract] [Full Text] [Related]

  • 36. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ.
    Curr Med Res Opin; 2007 Jun 06; 23(6):1453-62. PubMed ID: 17559741
    [Abstract] [Full Text] [Related]

  • 37. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
    Lutsep HL.
    J Stroke Cerebrovasc Dis; 2007 Jun 06; 16(6):263-7. PubMed ID: 18035244
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS, Skalabrin EJ, Kraiss LW.
    Am J Ther; 2009 Jun 06; 16(2):164-70. PubMed ID: 19300042
    [Abstract] [Full Text] [Related]

  • 40. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].
    Bousser MG, Eschwege E, Haguenau M, Lefauconnier JM, Touboul D, Touboul PJ.
    Rev Neurol (Paris); 1981 Jun 06; 137(5):333-41. PubMed ID: 7027408
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.